InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Simard John, Chairman & CEO. Officer active across 1 company, notably XBiotech Inc.. Aggregated, 7 disclosures have been recorded. Split: 0 buy · 7 sells. Total volume traded: €2m. Activity tracked since 14 July 2021. The latest transaction was filed on 15 October 2021 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
John Simard is Chief Executive Officer of XBiotech Inc. In this role, he oversees the company's operations and defines its overall strategy. Simard plays a key role in developing new treatments and innovation in the biotechnology field. His leadership is crucial for the growth of XBiotech.